...

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial

【24h】

Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial

机译：RNASEQ评估的肿瘤免疫细胞活性是HER2阴性乳腺癌患者Neoadjuvant化疗后治疗响应和预后的独立预测因子 - 对肝脏试验的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：RNASEQ评估的肿瘤免疫细胞活性是HER2阴性乳腺癌患者Neoadjuvant化疗后治疗响应和预后的独立预测因子 - 对肝脏试验的分析
2. Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). [J] . A Charehbili, S van de Ven, V T H B M Smit, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第5期

机译：在新辅助化疗中添加唑来膦酸不能增强HER2阴性II / III期乳腺癌患者的肿瘤反应：NEOZOTAC试验（BOOG，2010年1月）。
3. Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer [J] . Groheux David, Biard L., Lehmann-Che J., European Journal of Nuclear Medicine and Molecular Imaging . 2018,第8期

机译：通过基因组等级指数评估的FDG-PET / CT和肿瘤增殖评估的肿瘤代谢，以预测三重阴性乳腺癌中Neoadjuvant化疗的反应
4. Using Diffuse Optical Tomography to Monitor Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients [C] . Jacqueline E. Gunther, Emerson Lim, Hyun Keol Kim, Optical tomography and spectroscopy of tissue X . 2013

机译：使用漫射光学层析成像技术监测乳腺癌患者对新辅助化疗的肿瘤反应
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy [O] . Cui Jiang, Shuo Wu, Lei Jiang, -1

机译：基于网络的方法来识别预测紫杉烷-蒽环类新辅助化疗治疗HER2阴性乳腺癌的反应和预后的生物标志物
7. Utility of 18F-FDG PET/CT for Predicting Pathologic Complete Response in Luminal HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [O] . In Hee Lee, Soo Jung Lee, Jeeyeon Lee, 2020

机译：18F-FDG PET / CT用于预测腔HER2阴性乳腺癌患者病理完全反应的效用，接受Neoadjuvant化疗

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号